Type II Diabetes Patients under Sildenafil Citrate: Case Series Showing Benefits and a Side Effect
Background. Diabetes mellitus is a highly prevalent disease with rapid universal growth. In 2013, there were already 382 million people with diabetes, and it is expected that by 2035, this number will double. Chronic hyperglycemia causes a series of biochemical and structural changes, especially in...
Saved in:
Main Authors: | Livia M. Zimmermann, Mauricio S. Baptista, João Paulo Tardivo, Maria A. Pinhal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/4065452 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Validation of a Simple, Green Infrared Spectroscopic Method for Quantitation of Sildenafil Citrate in Siloflam Tablets of Unknown Manufacturing Formula
by: Van Trung Bui, et al.
Published: (2021-01-01) -
Sildenafil Treatment of Primary Pulmonary Hypertension
by: Kevin B Laupland, et al.
Published: (2003-01-01) -
Ranitidine bismuth citrate: A review
by: N Chiba, et al.
Published: (2001-01-01) -
Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat
by: Jasińska-Stroschein Magdalena, et al.
Published: (2014-09-01) -
Comparison of Milrinone with Sildenafil for the Treatment of Persistent Pulmonary Hypertension of the Newborn
by: Imtiaz Ahmad, et al.
Published: (2024-06-01)